Tikun Olam-Cannbit Pharmaceuticals Ltd

TASE:TKUN Voorraadrapport

Marktkapitalisatie: ₪31.7m

Tikun Olam-Cannbit Pharmaceuticals Beheer

Beheer criteriumcontroles 1/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Ronen Elad

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO1.3yrs
Eigendom CEO5.0%
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur4.2yrs

Recente managementupdates

Recent updates

Health Check: How Prudently Does Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Use Debt?

Oct 23
Health Check: How Prudently Does Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Use Debt?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Jun 21
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Has Debt But No Earnings; Should You Worry?

Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Apr 28
Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN) Stocks Shoot Up 27% But Its P/S Still Looks Reasonable

Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Jul 21
Risks To Shareholder Returns Are Elevated At These Prices For Tikun Olam-Cannbit Pharmaceuticals Ltd (TLV:TKUN)

Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Oct 03
Would Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Be Better Off With Less Debt?

Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Jun 03
Is Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Weighed On By Its Debt Load?

Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Oct 17
Tikun Olam-Cannbit Pharmaceuticals (TLV:TKUN) Is Carrying A Fair Bit Of Debt

Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

May 19
Is Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Using Debt Sensibly?

Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

Mar 19
Shareholders Of Tikun Olam - Cannbit Pharmaceuticals (TLV:TKUN) Must Be Happy With Their 135% Total Return

How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

Dec 02
How Much Did Tikun Olam - Cannbit Pharmaceuticals'(TLV:TKUN) Shareholders Earn From Share Price Movements Over The Last Five Years?

CEO

Ronen Elad (60 yo)

1.3yrs

Tenure

Mr. Ronen Elad is Chairman at Tikun Olam-Cannbit Pharmaceuticals Ltd since August 22, 2023 and also serves as its Co-CEO. He serves as the Chairman of Plastopil Hazorea Company Ltd. He is CEO, director and...


Bestuursleden

NaamPositieTenureCompensatieEigendom
Ronen Elad
Co-CEO & Chairman1.3yrsgeen gegevens5%
₪ 1.6m
Erez Navon
Director5.4yrsgeen gegevens2.7%
₪ 855.1k
Yaron Naor
Director5.4yrsgeen gegevens10.51%
₪ 3.3m
Yitzhak Ashkenazi
Independent Director5.1yrsgeen gegevens0.060%
₪ 19.1k
Ellit Mann Bitton
Independent External Director3.3yrsgeen gegevensgeen gegevens
Adi Zvulun
Director2.2yrsgeen gegevensgeen gegevens

4.2yrs

Gemiddelde duur

54yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van TKUN wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.2 jaar).